Initial Statement of Beneficial Ownership (3)
September 10 2021 - 6:08PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Satellite Overseas (Holdings) Ltd |
2. Date of Event Requiring Statement (MM/DD/YYYY)
8/31/2021
|
3. Issuer Name and Ticker or Trading Symbol
Generation Hemp, Inc. [GENH]
|
(Last)
(First)
(Middle)
7 HILL STREET |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director ___X___ 10% Owner _____ Officer (give title below) _____ Other (specify below)
|
(Street)
DOUGLAS, Y8 IM1 1EF
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY)
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 26263144 | I | See footnote (1) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Explanation of Responses: |
(1) | These shares are held directly by Satellite Overseas (Holdings) Limited, which is a wholly owned subsidiary of Cadila Pharmaceuticals Ltd. Cadila Pharmaceuticals Ltd. is owned by IRM Trust. Dr. Rajiv I. Modi is an executive officer and director of Cadila Pharmaceuticals Ltd. and a trustee of IRM Trust. Mr. Amitabha Banerjee is an executive officer of Cadila Pharmaceuticals Ltd. and a trustee of IRM Trust. Therefore Dr. Modi and Mr. Banerjee could be deemed to control IRM Trust, Cadila Pharmaceuticals (directly) and Satellite Overseas (Holdings) Limited (indirectly). |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Satellite Overseas (Holdings) Ltd 7 HILL STREET DOUGLAS, Y8 IM1 1EF |
| X |
|
|
Signatures
|
By: /s/ Dr. Rajiv I. Modi, Ph. D
Title: Director
Satellite Overseas (Holdings) Limited | | 9/10/2021 |
**Signature of Reporting Person | Date |
Generation Hemp (QB) (USOTC:GENH)
Historical Stock Chart
From May 2024 to Jun 2024
Generation Hemp (QB) (USOTC:GENH)
Historical Stock Chart
From Jun 2023 to Jun 2024